Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
04/2011
04/27/2011EP1521746B1 Quinazolinone modulators of nuclear receptors
04/27/2011EP1477175B1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
04/27/2011EP1439175B1 Pyrimidine compound and medicinal composition thereof
04/27/2011EP0934307B1 Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
04/27/2011CN1993346B Thiophene compound
04/27/2011CN102036982A Substituted pyridin-4-yl-methyl sulfonamides as fungicides
04/27/2011CN102036978A Novel thiophenediamine derivative having urea structure
04/27/2011CN102034933A Photoelectric conversion device, photoelectric conversion device material, photosensor and imaging device
04/27/2011CN102030737A Clinafloxacin amino derivatives and application thereof
04/27/2011CN101591295B Water-soluble benzopyrazolyl quaternary ammonium salt, preparation method thereof and application thereof
04/27/2011CN101525393B Oxime ester photoinitiator and preparation method thereof
04/27/2011CN101525333B Synthesis method of metixene hydrochloride
04/27/2011CN101370805B Novel pyridine derivatives
04/27/2011CN101284828B Cycloheptapyridine compounds, preparation method thereof, use and pharmaceutical compositions containing the compounds
04/27/2011CN101180298B New antibiotic derivatives
04/27/2011CN101033224B Novel pyrimidines small molecular compound, its preparation method and use
04/26/2011US7932272 Antifungal agent containing heterocyclic compound
04/26/2011US7932247 M3 muscarinic acetylcholine receptor antagonists
04/26/2011US7932246 Histone deacetylase inhibitors
04/26/2011CA2583742C 2,6-substituted-4-monosubstituted amino-pyrimidine as prostaglandin d2 receptor antagonists
04/26/2011CA2508474C Pesticidal sulphonylaminopyrazoles
04/26/2011CA2471059C Pyrimidine a2b selective antagonist compounds, their synthesis and use
04/26/2011CA2462416C Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist
04/26/2011CA2460145C Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
04/26/2011CA2446461C Substituted cyclohexane-1,4-diamine derivatives
04/21/2011WO2011047113A1 Process for the preparation of compounds useful as inhibitors of sglt2
04/21/2011WO2011046954A1 Hematopoietic growth factor mimetic small molecule compounds and their uses
04/21/2011WO2011045478A1 Dipyrannylidene derivatives as an anode interfacial layer in electronic devices
04/21/2011WO2011045415A2 New imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases
04/21/2011WO2011045355A1 Novel microbiocides
04/21/2011WO2011045292A1 Spiro-condensed cyclohexane derivatives as hsl inhibitors useful for the treatment of diabetes
04/21/2011WO2011045271A1 Herbicidally active, heterocyclyl-substituted pyridazinones
04/21/2011WO2011045084A1 Quinolinyloxyphenylsulfonamides
04/21/2011WO2011026911A8 Bipyridines useful for the treatment of proliferative diseases
04/21/2011WO2011004384A3 Process for the preparation of eprosartan
04/21/2011WO2008087558A3 Nucleoside and nucleotide analogues with quaternary carbon centers and methods of use
04/21/2011US20110092700 Novel Coumarin Derivative Having Antitumor Activity
04/21/2011US20110092612 Photoreactive composition, optical material, composition for forming holographic recording layer, holographic recording material, and holographic recording medium
04/21/2011US20110092553 Substituted Azole Derivatives, Compositions, and Methods of Use
04/21/2011US20110092503 Quinoline derivatives as axl kinase inhibitors
04/21/2011US20110092496 Thiophene compounds and thrombopoietin receptor activators
04/21/2011US20110092480 Substituted Heterocyclic Derivatives and Their Pharmaceutical Use and Compositions
04/21/2011US20110092461 Pyridyl inhibitors of hedgehog signalling
04/21/2011US20110091541 Preparation of formulations of angiotensin II at1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illnesses and its complications
04/21/2011CA2777528A1 Process for the preparation of compounds useful as inhibitors of sglt2
04/21/2011CA2777043A1 Substituted piperidines that increase p53 activity and the uses thereof
04/21/2011CA2776457A1 Spiro-condensed cyclohexane derivatives as hsl inhibitors useful for the treatment of diabetes
04/20/2011EP2311829A1 Substituted alkylamine derivatives and methods of use
04/20/2011EP2311828A1 Benzothiophene alkanol piperazine derivatives and their use as antidepressant
04/20/2011EP2311814A1 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between P53 and MDM2 proteins for use as anticancer agents
04/20/2011EP2311809A1 Quinolinyloxyphenylsulfonamides
04/20/2011EP2311808A1 Substituted alkylamine derivatives and methods of use
04/20/2011EP2311806A2 Dihydropyridine-, pyridine-, benzopyranone- and triazoloquinazoline derivatives, their preparation and their use as adenosine receptor antagonists
04/20/2011EP2311803A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
04/20/2011EP2311802A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
04/20/2011EP2311801A1 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
04/20/2011EP2310384A1 Inhibitors of janus kinases
04/20/2011EP2310362A1 Formation of 18f and 19f fluoroarenes bearing reactive functionalities
04/20/2011CN102026978A Pyridine compounds
04/20/2011CN102024907A Photoelectric conversion device, production method thereof, photosensor, imaging device and their drive methods
04/20/2011CN102020727A Pyrazole oxime ester photoinitiator with high photosensibility, preparation method and application thereof
04/20/2011CN102020607A 6-aminoniacinamide derivatives with histone deacetylase inhibiting activity, preparation method and application thereof
04/20/2011CN101429196B Preparation of halogenated pyridine substituted disulphur heterocycle hexane compounds
04/20/2011CN101039935B New piperidine antibiotics
04/20/2011CN101010312B Quaternary salt CCR2 antagonists
04/20/2011CN101010299B Six-membered heterocycles useful as serine protease inhibitors
04/19/2011US7928249 Conjugated monomers and polymers and preparation and use thereof
04/19/2011US7928224 Optically active quaternary ammonium salt having axial asymmetry and process for producing α-amino acid and derivative thereof with the same
04/19/2011US7928137 Meta-benzamidine derivatives as serine protease inhibitors
04/19/2011US7928131 Imidazole compounds
04/19/2011US7928127 Inhibitors of matrix metallaproteinases
04/19/2011US7928125 N-aroyl cyclic amine derivatives as orexin receptor antagonists
04/19/2011US7928124 N-aroyl cyclic amine derivatives as orexin receptor antagonists
04/19/2011US7928122 Modulators of cellular adhesion
04/19/2011US7927780 Resist composition, method of forming resist pattern, novel compound and method of producing the same, and acid generator
04/19/2011US7927717 Electroluminescent materials and devices
04/19/2011CA2628963C Benzene derivative or salt thereof
04/19/2011CA2621181C 5-isoquinolinesulfonamide compounds
04/19/2011CA2578047C Phenylaminopyridines
04/19/2011CA2560417C 1,2-diarylimidazole-4-carboxamide derivatives
04/19/2011CA2476012C Substituted pyridinones as modulators of p38 map kinase
04/19/2011CA2393802C 3-aminoquinazolin-2,4-dione antibacterial agents
04/16/2011CA2777223A1 2h-pyrrol-5-amine derivatives as alpha adrenergic receptor modulators
04/14/2011WO2011044535A2 8-ethyl-6-(aryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders
04/14/2011WO2011044229A1 2h-pyrrol-5-amine derivatives as alpha adrenergic receptor modulators
04/14/2011WO2011043479A1 Therapeutic agent for cerebral infarction
04/14/2011WO2011042477A1 Substituted pyrroles and imidazoles as estrogen receptor ligands
04/14/2011WO2011042475A1 Substituted pyrazoles as estrogen receptor ligands
04/14/2011WO2011042473A2 Novel estrogen receptor ligands
04/14/2011US20110087034 Organic Semiconductor Material
04/14/2011US20110086877 Small Molecule Inhibitors of Botulinum Neurotoxins
04/14/2011US20110086860 Compound
04/14/2011US20110086852 Pharmaceutical compounds
04/14/2011US20110086834 Alkynyl alcohols as kinase inhibitors
04/14/2011US20110086817 Anti-bacterial agents from benzo[d]heterocyclic scaffolds for prevention and treatment of multidrug resistant bacteria
04/14/2011US20110086073 NANOMETER-SIZED PRODRUGS OF NSAIDs
04/14/2011US20110083730 Derivatives or dipyrannylidene type as anode interface layer in electronic devices
04/14/2011CA2776770A1 8-ethyl-6-(aryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders
04/14/2011CA2776690A1 Heterocyclic compounds useful as pdk1 inhibitors
04/13/2011EP2309584A1 Dye for dye-sensitized solar cell, semiconductor electrode, and dye-sensitized solar cell
1 ... 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 ... 523